Precipio Inc stock is traded at $21.70, with a volume of 4,158. It is down -1.94% in the last 24 hours and up +1.52% over the past month. Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
Previous Close:
$22.13
Open:
$21.87
24h Volume:
4,158
Relative Volume:
0.20
Market Cap:
$38.91M
Revenue:
$25.83M
Net Income/Loss:
-$922.00K
P/E Ratio:
-
EPS:
-$0.5159
Net Cash Flow:
$555.00K
1W Performance:
-2.25%
1M Performance:
+1.52%
6M Performance:
-16.67%
1Y Performance:
+12.26%
1-Day Range:
$21.40$22.21
1-Week Range:
$21.40$25.34
52-Week Range:
$17.79$33.63
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
203 787 7888Address
4 SCIENCE PARK, NEW HAVEN, CT, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS